Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Journal of Veterinary Research
Volume 62 (2018): Issue 2 (June 2018)
Open Access
Influence of inosine pranobex on cell viability in normal fibroblasts and liver cancer cells
Sylwia Tobólska
Sylwia Tobólska
,
Sylwia Terpiłowska
Sylwia Terpiłowska
,
Jerzy Jaroszewski
Jerzy Jaroszewski
and
Andrzej Krzysztof Siwicki
Andrzej Krzysztof Siwicki
| Jul 07, 2018
Journal of Veterinary Research
Volume 62 (2018): Issue 2 (June 2018)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Jul 07, 2018
Page range:
215 - 220
Received:
Mar 29, 2018
Accepted:
Jun 21, 2018
DOI:
https://doi.org/10.2478/jvetres-2018-0031
Keywords
inosine pranobex
,
cell culture
,
cytotoxicity
© 2018 Sylwia Tobólska et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Fig. 1
Cytotoxicity of inosine pranobex in BALB/ 3T3 clone A31 and HepG2 lines detected with the MTT assay, n = 6. Values are given as percentage of cell viability relative to control cells. *P < 0.05, compared with control cells
Fig. 2
Cytotoxicity of inosine pranobex in BALB/3T3 clone A31 and HepG2 lines detected with the LDH assay, n = 6. Values are given as percentage of LDH released. *P < 0.05, compared with control cells
Fig. 3
Cytotoxicity of inosine pranobex in BALB/3T3 clone A31 and HepG2 lines detected with the NRU assay, n = 6. Values are given as percentage of cell viability relative to control cells. *P < 0.05, compared with control cells
Cytotoxicity of inosine pranobex. Inhibitory concentration (IC50, μg/mL)
BALB/ 3T3 clone A31 line
HepG2 line
MTT reduction assay
500
50
LDH release assay
100
10
NRU assay
500
100